Design and Evaluation of Eb4Mab-7-mG2a: A Dual-Action Anti-EphB4 Monoclonal Antibody for Targeted Breast Cancer Therapy

Tomokazu Ohishi(Microbial Chemistry Research Foundation), Manabu Kawada(Microbial Chemistry Research Foundation)

Preprints.org

July 1, 2025

10.20944/preprints202506.2503.v1

Cited by 0

Related Papers

Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2

|PLoS ONE|2022|45

Structures and biological activities of novel 4’-acetylated analogs of chrysomycins A and B

|The Journal of Antibiotics|2017|22

NBRI17671, a new antitumor compound, produced by Acremonium sp. CR17671

|The Journal of Antibiotics|2010|9

Pancreatic Stromal Cell-derived Oncostatin M Confers Drug Resistance to a Multi-tyrosine Kinase Inhibitor in Pancreatic Cancer Cells

|Anticancer Research|2023|4